Stay updated on Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.

Latest updates to the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page
- CheckyesterdayChange DetectedNo significant changes to the study content were observed; only minor formatting and layout updates appear on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision: v3.3.4 was added, replacing the previous revision v3.3.3.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded a Locations section with state-level site listings (California, Florida, Massachusetts, Missouri, New York, Pennsylvania, Washington) and updated the page revision to v3.3.3; removed the previous per-state location entries and the HHS Vulnerability Disclosure link (reflecting the change from v3.3.2 to v3.3.3).SummaryDifference0.8%

- Check44 days agoChange DetectedNo significant changes to the Study Details page for NCT03063632; the content remains the same, with only minor layout differences observed.SummaryDifference0.1%

- Check58 days agoChange DetectedPublication provenance text updated to indicate PubMed automatic filling (may not be about the study) and the revision tag changed from v3.2.0 to v3.3.2.SummaryDifference0.2%

- Check65 days agoChange DetectedThe government funding/operating status notice was removed from the page.SummaryDifference0.3%

Stay in the know with updates to Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining MK-3475 and Interferon-gamma in Sarcoma Clinical Trial page.